GLG News by Neonatal-Perinatal Physicians

Eventually, although not likely in the next ten years, electronic medical records (EMRs) will be the norm; once the interoperability issues are addressed, these records will be sharable across various networks. Until that time, systems such as Google's might serve some purpose.   &nb...

The alpha adrfenergic side effects of current treatments for BPH are significantly limiting in the use of these drugs.

Novel delivery systems will generally be the next wave, whether for topical medications such as retinoic acid or systemic compounds, where the delivery system can target specific receptors or organs.

Rating physicians is not like rating hotels, airlines or restaurants. Unfortunately, the comments of lay people can only go so far in assessing a physician's performance.

-Dry powder inhalers (DPIs) for kids are big news as traditional MDIs can be hard to use -If the device is easy to use, other meds (like albuterol) might be made available to use this way as well

It would be great to be able to treat asthma and get steroid-like efficacy without the side effects. But there is not much to say without additional details.   

Vaccines have been shown again and again to be cost-effective tools. Fortunately, pediatric vaccines are generally given, since the schools enforce the requirements. But adults would benefit as well.

Dry powder inhalers are easier for many young children to use than metered dose inhalers. This approval makes it possible to use a popular drug in younger patients who might not be able to use the MDI format.

As is so often the case, the long-term benefits or risks of a particular therapy can only be evaluated by equally long-term studies. And the marketing and patent facts of life mean that drugs are released and pushed before all the data (or even sufficient data) is in, often with disastrous effects.

Pediatric psoriasis has always been difficult to treat without toxicity. Enbrel appears to have both efficacy and safety in this condition.